MRK dividend yield: 3.25%. MSFT dividend yield: 0.72%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. Microsoft has grown its dividend 10%+ annually for a decade, making it one of the best dividend growth stories in tech. Azure cloud dominance and AI integration (Copilot) drive strong cash generation. Low payout ratio of ~24% means dividends are extremely safe with significant room to grow.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Microsoft has grown its dividend 10%+ annually for a decade, making it one of the best dividend growth stories in tech. Azure cloud dominance and AI integration (Copilot) drive strong cash generation. Low payout ratio of ~24% means dividends are extremely safe with significant room to grow.
Is MRK or MSFT better for dividend income in 2026?
MRK currently offers a 3.25% yield (3.08/share/year) while MSFT offers 0.72% (3.00/share/year). MRK provides higher current income. However, MSFT has grown its dividend faster (10.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs MSFT earn per year?
With $10,000 invested today: MRK pays approximately $325/year. MSFT pays approximately $72/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $199/year (MSFT).
Does MRK or MSFT pay monthly dividends?
MRK pays quarterly dividends. MSFT pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs MSFT comparison by email
Save your analysis + get weekly dividend insights. Free forever.